Researchers at Zhejiang University School of Medicine have identified a single point mutation in the normal PML gene that can block the effect of arsenic trioxide, a frontline drug for acute ...
Acute promyelocytic leukaemia (APL) is a distinct subtype of acute myeloid leukaemia driven by the PML-RARA fusion oncoprotein, which blocks differentiation of myeloid precursors at the promyelocyte ...
Combining all-trans retinoic acid (ATRA) with arsenic trioxide (ATO) and idarubicin significantly improved event-free survival (EFS) compared with the standard treatment of ATRA and ...
The use of a simplified treatment regimen by oncologists, along with management recommendations and 24/7 support provided by a limited and dedicated group of academic disease experts, resulted in a ...
Researchers at Zhejiang University School of Medicine have identified a single point mutation in the normal PML gene that can block the effect of arsenic trioxide, a frontline drug for acute ...
Please provide your email address to receive an email when new articles are posted on . All patients who received the oral regimen achieved an initial complete remission. Survival rates remain more ...
APOLLO: Optimizing the Treatment of High-Risk Acute Promyelocytic Leukemia With All-Trans Retinoic Acid and Arsenic Trioxide While Minimizing the Role of Chemotherapy The following represents ...
BM -Bone Marrow; WBC max- Maximum WBC before starting venetoclax; CAD-Coronary Artery Disease; RHD- Rheumatic Heart Disease; HCR-Hematological Complete Response. This is an ASCO Meeting Abstract from ...
Verywell Health on MSN
How leukemia is treated
Medically reviewed by Douglas A. Nelson, MD The treatment for leukemia depends on many factors, including the type, subtype, and stage of the disease, and a person’s age and general health. Treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results